Replimune (NASDAQ: REPL) CFO awarded 75,000 options and 50,000 RSUs
Rhea-AI Filing Summary
Replimune Group, Inc. Chief Financial Officer Emily Luisa Hill reported receiving new equity awards. She was granted an employee stock option for 75,000 shares of common stock at an exercise price of $7.61 per share, expiring on April 1, 2036. Twenty-five percent of this option vests on April 1, 2027, with the rest vesting in 36 approximately equal monthly installments.
Hill was also granted 50,000 restricted stock units (RSUs), each representing one share of common stock. Twenty-five percent of these RSUs vest on May 15, 2027, with the remainder vesting in three approximately equal annual installments until May 15, 2030, subject to continued service. Following the RSU grant, her direct common stock holdings increased to 244,368 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 50,000 shares
Net Buy
2 txns
Insider
Hill Emily Luisa
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 75,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 75,000 shares (Direct);
Common Stock — 244,368 shares (Direct)
Footnotes (2)
- F1. Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer.
- F2. 25% of the shares underlying this stock option vest on April 1, 2027, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
Key Figures
Stock options granted: 75,000 shares
Option exercise price: $7.61 per share
Option expiration: April 1, 2036
+4 more
7 metrics
Stock options granted
75,000 shares
Employee stock option granted on April 1, 2026
Option exercise price
$7.61 per share
Strike price of 75,000-share employee stock option
Option expiration
April 1, 2036
Expiry date of employee stock option grant
RSUs granted
50,000 units
Restricted stock units granted to CFO on April 1, 2026
RSU initial vesting date
May 15, 2027
25% of RSUs vest on this date
Common stock holdings after grant
244,368 shares
Direct holdings after RSU award
Option first vesting date
April 1, 2027
25% of option shares vest on this date
Key Terms
Employee Stock Option (right to buy), restricted stock units ("RSUs"), vest, exercise price, +1 more
5 terms
Employee Stock Option (right to buy) financial
"security_title: Employee Stock Option (right to buy)"
restricted stock units ("RSUs") financial
"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vest financial
"25% of the RSUs will vest on May 15, 2027 and the remainder will vest"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: 7.6100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
contingent right financial
"Each RSU represents a contingent right to receive one share"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Replimune (REPL) CFO Emily Hill receive?
Replimune CFO Emily Hill received stock options for 75,000 shares at $7.61 per share and 50,000 restricted stock units. These awards are part of her compensation and vest over several years, subject to her continued service with the company.
How do Emily Hill’s new stock options at Replimune (REPL) vest?
Emily Hill’s 75,000-share stock option vests 25% on April 1, 2027, with the remaining shares vesting in 36 approximately equal monthly installments. The option has an exercise price of $7.61 and expires on April 1, 2036, aligning incentives over the long term.
What is the vesting schedule for the 50,000 RSUs granted to Replimune (REPL) CFO?
The 50,000 RSUs granted to Replimune’s CFO vest 25% on May 15, 2027, with the remaining RSUs vesting in three approximately equal annual installments through May 15, 2030. Each RSU converts into one share of common stock upon settlement.
Are Emily Hill’s Replimune (REPL) equity awards open-market purchases?
No. The Form 4 shows code “A” transactions, indicating grant or award acquisitions, not open-market purchases. The 75,000 stock options and 50,000 RSUs were granted as compensation, with zero transaction price and multi-year vesting schedules tied to ongoing service.
When do Emily Hill’s new Replimune (REPL) stock options expire?
The 75,000-share employee stock option granted to Emily Hill expires on April 1, 2036. This long-dated option, with a $7.61 exercise price and staged vesting from 2027 onward, is designed to align her incentives with Replimune’s long-term performance.